{"DataElement":{"publicId":"4986358","version":"1","preferredName":"Digestive System Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for digestive system neuroendocrine tumor.","longName":"4985527v1.0:4986161v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"4985527","version":"1","preferredName":"Neuroendocrine Neoplasm Stage Grouping","preferredDefinition":"A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"4985525v1.0:2230143v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"4985525","version":"1","preferredName":"Neuroendocrine Neoplasm","preferredDefinition":"A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.","longName":"C3809","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Neoplasm","conceptCode":"C3809","definition":"An epithelial neoplasm with neuroendocrine differentiation. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2B7374-A356-3BA5-E050-BB89AD431881","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2B7374-A364-3BA5-E050-BB89AD431881","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4986161","version":"1","preferredName":"Digestive System Neuroendocrine Neoplasm American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A neoplasm with neuroendocrine differentiation arising from the digestive system.  It includes neuroendocrine tumors (well-differentiated endocrine tumors or carcinoid tumors and well differentiated endocrine carcinomas) and neuroendocrine carcinomas (poorly differentiated neuroendocrine carcinomas, small cell carcinomas, and large cell neuroendocrine carcinomas)._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"4986161v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IIIB","valueDescription":"Stage IIIB Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986163","version":"1","preferredName":"Stage IIIB Digestive System Neuroendocrine Neoplasm","longName":"4986163","preferredDefinition":"Stage IIIB includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88032","definition":"Stage IIIB includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7D6C-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7D85-308A-E050-BB89AD435DB5","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986165","version":"1","preferredName":"Stage IIIA Digestive System Neuroendocrine Neoplasm","longName":"4986165","preferredDefinition":"Stage IIIA includes: T4, N0, M0.  T4: Stomach/duodenum/ampulla/jejunum/ileum: tumor invades visceral peritoneum (serosa) or invades other organs or adjacent structures; colon or rectum: tumor invades peritoneum or other organs.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88031","definition":"Stage IIIA includes: T4, N0, M0.  T4: Stomach/duodenum/ampulla/jejunum/ileum: tumor invades visceral peritoneum (serosa) or invades other organs or adjacent structures; colon or rectum: tumor invades peritoneum or other organs.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7D92-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7DAB-308A-E050-BB89AD435DB5","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986167","version":"1","preferredName":"Stage I Digestive System Neuroendocrine Neoplasm","longName":"4986167","preferredDefinition":"Stage I includes: T1, N0, M0.  T1: Stomach: tumor invades lamina propria or submucosa and is 1 cm or less in size; duodenum /jejunum/ileum: tumor invades lamina propria or submucosa and is 1 cm or less in size; ampulla: tumor 1 cm or less; colon or rectum: tumor invades lamina propria or submucosa and is 2 cm or less.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88028","definition":"Stage I includes: T1, N0, M0.  T1: Stomach: tumor invades lamina propria or submucosa and is 1 cm or less in size; duodenum /jejunum/ileum: tumor invades lamina propria or submucosa and is 1 cm or less in size; ampulla: tumor 1 cm or less; colon or rectum: tumor invades lamina propria or submucosa and is 2 cm or less.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7DB8-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7DD1-308A-E050-BB89AD435DB5","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986169","version":"1","preferredName":"Stage 0 Digestive System Neuroendocrine Neoplasm","longName":"4986169","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis (applies only to stomach): Carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88027","definition":"Stage 0 includes: Tis, N0, M0.  Tis (applies only to stomach): Carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7DDE-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7DF7-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986171","version":"1","preferredName":"Stage IIA Digestive System Neuroendocrine Neoplasm","longName":"4986171","preferredDefinition":"Stage IIA includes: T2, N0, M0.  T2: Stomach/ duodenum /jejunum/ileum: tumor invades muscularis propria or is more than 1 cm in size; ampulla: tumor is more than 1 cm in size; colon or rectum: tumor invades muscularis propria or is more than 2 cm in size with invasion of lamina propria or submucosa.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88029","definition":"Stage IIA includes: T2, N0, M0.  T2: Stomach/ duodenum /jejunum/ileum: tumor invades muscularis propria or is more than 1 cm in size; ampulla: tumor is more than 1 cm in size; colon or rectum: tumor invades muscularis propria or is more than 2 cm in size with invasion of lamina propria or submucosa.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7E04-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7E1D-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986173","version":"1","preferredName":"Stage IIB Digestive System Neuroendocrine Neoplasm","longName":"4986173","preferredDefinition":"Stage IIB includes: T3, N0, M0.  T3: Stomach: tumor penetrates subserosa; jejunum/ileum: tumor invades through the muscularis propria into subserosal tissue without penetration of overlying serosa or invades into non-peritonealized tissues; ampulla/duodenum: tumor invades pancreas or retroperitoneum or into non-peritonealized tissues; colon or rectum: tumor invades through the muscularis propria into the subserosa, or into non-peritonealized pericolic or perirectal tissues. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88030","definition":"Stage IIB includes: T3, N0, M0.  T3: Stomach: tumor penetrates subserosa; jejunum/ileum: tumor invades through the muscularis propria into subserosal tissue without penetration of overlying serosa or invades into non-peritonealized tissues; ampulla/duodenum: tumor invades pancreas or retroperitoneum or into non-peritonealized tissues; colon or rectum: tumor invades through the muscularis propria into the subserosa, or into non-peritonealized pericolic or perirectal tissues. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7E2A-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7E43-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Digestive System Neuroendocrine Neoplasm","ValueMeaning":{"publicId":"4986175","version":"1","preferredName":"Stage IV Digestive System Neuroendocrine Neoplasm","longName":"4986175","preferredDefinition":"Stage IV includes: Any T, Any N, M1. M1: Distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Digestive System Neuroendocrine Tumor AJCC v7","conceptCode":"C88033","definition":"Stage IV includes: Any T, Any N, M1. M1: Distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7E50-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7E69-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7E73-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4986160","version":"1","preferredName":"Digestive System Neuroendocrine Neoplasm American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A neoplasm with neuroendocrine differentiation arising from the digestive system.  It includes neuroendocrine tumors (well-differentiated endocrine tumors or carcinoid tumors and well differentiated endocrine carcinomas) and neuroendocrine carcinomas (poorly differentiated neuroendocrine carcinomas, small cell carcinomas, and large cell neuroendocrine carcinomas).:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C27721:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Digestive System Neuroendocrine Neoplasm","conceptCode":"C27721","definition":"A neoplasm with neuroendocrine differentiation arising from the digestive system. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7D40-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7D51-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"MAESKEB","dateModified":"2017-04-11","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"4985894","version":"1","longName":"Neuroendocrine","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777526","version":"1","longName":"Neuroendocrine ","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCIP"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"1E3CB43D-B872-63BE-E050-BB89AD432CD5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created by COG request for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}